Do you want to read an article? Please log in or register.
Rationale, Design, and Experiences from the Vanguard Phase of the Bariatric Surgery for the Reduction of Cardiovascular Events (BRAVE) Trial
Further Publications
Related content
Cardiovascular Risk and DiseasesFurther Publications
Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial: Interleukin-6 Inhibition and Atherosclerotic Event Rate Reduction
JAMA Cardiol
Ridker PM, Baeres FMM, Hveplund A, Engelmann MMD, Hovingh GK, Lincoff AM, Marx N, Navar AM, Sattar N, Tuttle K, Perkovic V
doi: 10.1001/jamacardio.2025.4491
Cardiac Arrest or Death
Design and rationale of A Multicenter Paramedic randomized trial of noradrenaline versus adrenaline in the initial management of patients with cardiogenic shock - The PANDA trial
Am Heart J
Bloom JE, Ball J, Okyere D, Voskoboinik A, Dawson LP, Nelson AJ, Percival M, Meadley B, Salathiel R, McManamny T, Boggett S, Batchelor R, Hartshorne T, Palmer S, Reid C, Anderson D, Pilcher D, Chew DP, Kaye DM, Nehme Z, Stub D, PANDA Investigators
doi: 10.1016/j.ahj.2026.107378
Atrial Fibrillation
Left atrial appendage occlusion versus NOACs in patients with atrial fibrillation: Rationale and design of the CATALYST Trial
Am Heart J
Reddy VY, Hylek E, Camm AJ, Halperin JL, Diener HC, Thaler D, Schmidt B, Hara H, Huisman MV, Price MJ, Lakkireddy D, Gage R, Zhao H, Jensen TP, Quintana M, Windecker S
doi: 10.1016/j.ahj.2026.107367
RECOMMENDED
Further Publications
Long-Term Effectiveness of Intensive Blood Pressure Management Led by Nonphysician Community Healthcare Providers on Cardiovascular Events: 7-Year Follow-Up of a Cluster Randomized Trial
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Circulation
Sun G, Guo X, Zhao C, Ouyang N, Li G, Wang C, Ren Y, Xing L, Sun Z, Qiao L, Zhong S, Liu S, Yin Y, Yu Y, Tan X, Zhang C, He C, Jiang X, Chen Y, Wang D, Sun Y, CRHCP Study Group
doi: 10.1161/CIRCULATIONAHA.126.082511
Atrial Fibrillation
Integrated Care Management for Older Multimorbid Patients with Atrial Fibrillation: Rationale, Design and Baseline Characteristics for the Atrial Fibrillation Integrated Approach in Frail, Multimorbid and Polymedicated Older People (AFFIRMO) trial
Am Heart J
Proietti M, Lip GYH, Ainsworth J, Dan GA, Frost L, Graffigna G, Lucci D, Marin F, Potpara TS, Sanaullah A, Tokmakova M, Johnsen SP, Maggioni AP, AFFIRMO Study Investigators and Consortium
doi: 10.1016/j.ahj.2026.107356
Cardiovascular Risk and Diseases
Comparative Effectiveness of Individual Sodium Glucose Transporter 2 Inhibitors on Cardiovascular Outcomes in Type 2 Diabetes With Moderate Cardiovascular Risk: Emulation of a Target Trial
J Am Heart Assoc
Zehra A, Deng Y, Swarna KS, Herrin J, Polley EC, Neumiller JJ, Galindo RJ, Umpierrez GE, Ross JS, Brito JP, Montori VM, Borah BJ, Maron BA, Mickelson MM, McCoy RG
doi: 10.1161/JAHA.125.046238
Cardiovascular Risk and DiseasesHeart, Artery and Coronary Diseases
Toward a Deeper Understanding of Predicting Risk of Cardiovascular Disease Events for 10-Year Atherosclerotic Cardiovascular Risk: Subgroup Fairness and Predictive Value of Social Determinants of Health
J Am Heart Assoc
Wang H, Tian Z, Bhattacharya R, Niu M, Sang Y, Wojdyla DM, Hong H, Zhao J, Pignone M, Hall JL, Khan SS, Engelhard M, Pencina MJ, Hong C
doi: 10.1161/JAHA.125.046186
Cardiovascular Risk and Diseases
Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease: An Exploratory Analysis of the SELECT Randomized Clinical Trial
JAMA Cardiol
Nicholls SJ, Ryan DH, Deanfield J, Ferreira D, Lang CC, Lincoff AM, Lingvay I, Lübker C, Terns PP, Rasmussen S, Stensen S, Weeke PE, Kahn SE, SELECT Trial Investigators
doi: 10.1001/jamacardio.2025.4824
Further Publications
Finerenone Across Cardiovascular-Kidney-Metabolic Syndrome Stages: Post Hoc Analysis of the FIDELITY Randomized Clinical Trials
JAMA Cardiol
Lo KB, Ostrominski JW, Hamatani Y, Claggett BL, Agarwal R, Anker SD, Filippatos G, Rossing P, Ruilope LM, Pitt B, Briasoulis A, Stamatelopoulos K, Brinker M, Schloemer P, Glasauer A, Solomon SD, Vaduganathan M
doi: 10.1001/jamacardio.2026.1365